Orphapacket:
  AverageAgeOfOnsets:
    AverageAgeOfOnset:
    - value: Infancy
  Childs:
  - Child:
      Genes:
      - Gene:
          DisorderGeneAssociationType: Disease-causing germline mutation(s) (loss
            of function) in
          ExternalReferences:
          - Reference: '8582'
            Source: HGNC
          - Reference: '612349'
            Source: OMIM
          Label: phenylalanine hydroxylase
          Symbol: PAH
      Label: Mild phenylketonuria
      ORPHAcode: '79253'
  - Child:
      Genes:
      - Gene:
          DisorderGeneAssociationType: Disease-causing germline mutation(s) (loss
            of function) in
          ExternalReferences:
          - Reference: '8582'
            Source: HGNC
          - Reference: '612349'
            Source: OMIM
          Label: phenylalanine hydroxylase
          Symbol: PAH
      Label: Classic phenylketonuria
      ORPHAcode: '79254'
  - Child:
      Genes:
      - Gene:
          DisorderGeneAssociationType: Disease-causing germline mutation(s) (loss
            of function) in
          ExternalReferences:
          - Reference: '8582'
            Source: HGNC
          - Reference: '612349'
            Source: OMIM
          Label: phenylalanine hydroxylase
          Symbol: PAH
      Label: Mild hyperphenylalaninemia
      ORPHAcode: '79651'
  - Child:
      Genes:
      - Gene:
          DisorderGeneAssociationType: Disease-causing germline mutation(s) in
          ExternalReferences:
          - Reference: '8582'
            Source: HGNC
          - Reference: '612349'
            Source: OMIM
          Label: phenylalanine hydroxylase
          Symbol: PAH
      Label: Tetrahydrobiopterin-responsive hyperphenylalaninemia/phenylketonuria
      ORPHAcode: '293284'
  DisorderType:
    PURL: http://www.orpha.net/ORDO/Orphanet_377788
    value: Disease
  ExternalReferences:
  - DisorderMappingRelation: 'E (Exact mapping: the two concepts are equivalent)'
    Reference: '261600'
    Source: OMIM
  Label: Phenylketonuria
  ORPHAcode: '716'
  ORPHApacketId: '716'
  PURL: http://www.orpha.net/ORDO/Orphanet_716
  Parents:
  - Parent:
    - Label: Neurometabolic disease
      ORPHAcode: '68385'
  - Parent:
    - Label: Disorder of phenylalanine metabolism
      ORPHAcode: '284814'
  - Parent:
    - Label: Amino acid or protein metabolism disease with epilepsy
      ORPHAcode: '225689'
  Phenotypes:
  - Phenotype:
      HPOFrequency: Very frequent (99-80%)
      HPOId: HP:0003355
      HPOTerm: Aminoaciduria
  - Phenotype:
      HPOFrequency: Frequent (79-30%)
      HPOId: HP:0010864
      HPOTerm: Intellectual disability, severe
  - Phenotype:
      HPOFrequency: Occasional (29-5%)
      HPOId: HP:0030680
      HPOTerm: Abnormality of cardiovascular system morphology
  Prevalences:
  - Prevalence:
      PrevalenceClass: 1-9 / 100 000
      PrevalenceGeographic: France
      PrevalenceQualification: Value and class
      PrevalenceType: Prevalence at birth
      Source: "11641035[PMID]_17616847[PMID]_[EXPERT]_Haute Autorit\xE9 de Sant\xE9\
        \ 2010[INST]"
      ValMoy: no data
  - Prevalence:
      PrevalenceClass: 1-5 / 10 000
      PrevalenceGeographic: France
      PrevalenceQualification: Value and class
      PrevalenceType: Point prevalence
      Source: 32668217[PMID]
      ValMoy: no data
  - Prevalence:
      PrevalenceClass: 1-5 / 10 000
      PrevalenceGeographic: Europe
      PrevalenceQualification: Value and class
      PrevalenceType: Prevalence at birth
      Source: 34082800[PMID]_ORPHANET
      ValMoy: no data
  - Prevalence:
      PrevalenceClass: 1-5 / 10 000
      PrevalenceGeographic: Europe
      PrevalenceQualification: Value and class
      PrevalenceType: Point prevalence
      Source: 32668217[PMID]
      ValMoy: no data
  - Prevalence:
      PrevalenceClass: 1-9 / 100 000
      PrevalenceGeographic: United Kingdom
      PrevalenceQualification: Value and class
      PrevalenceType: Prevalence at birth
      Source: 34082800[PMID]_ORPHANET
      ValMoy: no data
  - Prevalence:
      PrevalenceClass: 1-5 / 10 000
      PrevalenceGeographic: United Kingdom
      PrevalenceQualification: Value and class
      PrevalenceType: Point prevalence
      Source: 32668217[PMID]
      ValMoy: no data
  - Prevalence:
      PrevalenceClass: 1-5 / 10 000
      PrevalenceGeographic: Ireland
      PrevalenceQualification: Value and class
      PrevalenceType: Prevalence at birth
      Source: 9254847[PMID]_[EXPERT]
      ValMoy: no data
  - Prevalence:
      PrevalenceClass: 1-5 / 10 000
      PrevalenceGeographic: Ireland
      PrevalenceQualification: Value and class
      PrevalenceType: Point prevalence
      Source: 32668217[PMID]
      ValMoy: no data
  - Prevalence:
      PrevalenceClass: 1-9 / 1 000 000
      PrevalenceGeographic: Finland
      PrevalenceQualification: Class only
      PrevalenceType: Prevalence at birth
      Source: 8825928[PMID]_[EXPERT]
      ValMoy: no data
  - Prevalence:
      PrevalenceClass: 1-9 / 1 000 000
      PrevalenceGeographic: Finland
      PrevalenceQualification: Value and class
      PrevalenceType: Point prevalence
      Source: 32668217[PMID]
      ValMoy: no data
  - Prevalence:
      PrevalenceClass: 1-9 / 100 000
      PrevalenceGeographic: United States
      PrevalenceQualification: Value and class
      PrevalenceType: Prevalence at birth
      Source: 34082800[PMID]_ORPHANET
      ValMoy: no data
  - Prevalence:
      PrevalenceClass: 1-9 / 100 000
      PrevalenceGeographic: United States
      PrevalenceQualification: Value and class
      PrevalenceType: Point prevalence
      Source: 32668217[PMID]
      ValMoy: no data
  - Prevalence:
      PrevalenceClass: 1-9 / 100 000
      PrevalenceGeographic: Latin America
      PrevalenceQualification: Value and class
      PrevalenceType: Prevalence at birth
      Source: 34082800[PMID]_ORPHANET
      ValMoy: no data
  - Prevalence:
      PrevalenceClass: 1-9 / 100 000
      PrevalenceGeographic: Latin America
      PrevalenceQualification: Value and class
      PrevalenceType: Point prevalence
      Source: 32668217[PMID]_ORPHANET
      ValMoy: no data
  - Prevalence:
      PrevalenceClass: 1-9 / 100 000
      PrevalenceGeographic: Brazil
      PrevalenceQualification: Value and class
      PrevalenceType: Prevalence at birth
      Source: 34082800[PMID]_ORPHANET
      ValMoy: no data
  - Prevalence:
      PrevalenceClass: 1-9 / 100 000
      PrevalenceGeographic: Brazil
      PrevalenceQualification: Value and class
      PrevalenceType: Point prevalence
      Source: 32668217[PMID]
      ValMoy: no data
  - Prevalence:
      PrevalenceClass: 1-9 / 100 000
      PrevalenceGeographic: Australia
      PrevalenceQualification: Value and class
      PrevalenceType: Prevalence at birth
      Source: 34082800[PMID]_ORPHANET
      ValMoy: no data
  - Prevalence:
      PrevalenceClass: 1-9 / 100 000
      PrevalenceGeographic: Australia
      PrevalenceQualification: Value and class
      PrevalenceType: Point prevalence
      Source: 32668217[PMID]
      ValMoy: no data
  - Prevalence:
      PrevalenceClass: 1-5 / 10 000
      PrevalenceGeographic: Iceland
      PrevalenceQualification: Value and class
      PrevalenceType: Prevalence at birth
      Source: 21659675[PMID]
      ValMoy: no data
  - Prevalence:
      PrevalenceClass: 1-5 / 10 000
      PrevalenceGeographic: Iceland
      PrevalenceQualification: Value and class
      PrevalenceType: Point prevalence
      Source: 32668217[PMID]
      ValMoy: no data
  - Prevalence:
      PrevalenceClass: 1-9 / 100 000
      PrevalenceGeographic: Japan
      PrevalenceQualification: Value and class
      PrevalenceType: Prevalence at birth
      Source: 6468444[PMID]_20971365[PMID]_ ORPHANET
      ValMoy: no data
  - Prevalence:
      PrevalenceClass: 1-9 / 1 000 000
      PrevalenceGeographic: Japan
      PrevalenceQualification: Value and class
      PrevalenceType: Point prevalence
      Source: 32668217[PMID]
      ValMoy: no data
  - Prevalence:
      PrevalenceClass: 1-9 / 100 000
      PrevalenceGeographic: China
      PrevalenceQualification: Value and class
      PrevalenceType: Prevalence at birth
      Source: 34082800[PMID]_ORPHANET
      ValMoy: no data
  - Prevalence:
      PrevalenceClass: 1-9 / 100 000
      PrevalenceGeographic: China
      PrevalenceQualification: Value and class
      PrevalenceType: Point prevalence
      Source: 32668217[PMID]
      ValMoy: no data
  - Prevalence:
      PrevalenceClass: 1-9 / 100 000
      PrevalenceGeographic: Thailand
      PrevalenceQualification: Value and class
      PrevalenceType: Prevalence at birth
      Source: 32668217[PMID]
      ValMoy: no data
  - Prevalence:
      PrevalenceClass: 1-9 / 1 000 000
      PrevalenceGeographic: Thailand
      PrevalenceQualification: Value and class
      PrevalenceType: Point prevalence
      Source: 32668217[PMID]
      ValMoy: no data
  - Prevalence:
      PrevalenceClass: 1-9 / 100 000
      PrevalenceGeographic: Turkey
      PrevalenceQualification: Value and class
      PrevalenceType: Prevalence at birth
      Source: 34082800[PMID]_ORPHANET
      ValMoy: no data
  - Prevalence:
      PrevalenceClass: 1-5 / 10 000
      PrevalenceGeographic: Turkey
      PrevalenceQualification: Value and class
      PrevalenceType: Point prevalence
      Source: 32668217[PMID]
      ValMoy: no data
  - Prevalence:
      PrevalenceClass: 1-9 / 100 000
      PrevalenceGeographic: United Arab Emirates
      PrevalenceQualification: Value and class
      PrevalenceType: Prevalence at birth
      Source: 34082800[PMID]
      ValMoy: no data
  - Prevalence:
      PrevalenceClass: 1-9 / 100 000
      PrevalenceGeographic: United Arab Emirates
      PrevalenceQualification: Value and class
      PrevalenceType: Point prevalence
      Source: 32668217[PMID]
      ValMoy: no data
  - Prevalence:
      PrevalenceClass: 1-5 / 10 000
      PrevalenceGeographic: Jordan
      PrevalenceQualification: Value and class
      PrevalenceType: Point prevalence
      Source: 32668217[PMID]
      ValMoy: no data
  - Prevalence:
      PrevalenceClass: 1-9 / 100 000
      PrevalenceGeographic: Jordan
      PrevalenceQualification: Value and class
      PrevalenceType: Prevalence at birth
      Source: DOI:10.1007/978-3-642-05080-0_11[OTHER]
      ValMoy: no data
  - Prevalence:
      PrevalenceClass: 1-9 / 100 000
      PrevalenceGeographic: India
      PrevalenceQualification: Value and class
      PrevalenceType: Point prevalence
      Source: 32668217[PMID]
      ValMoy: no data
  - Prevalence:
      PrevalenceClass: 1-9 / 100 000
      PrevalenceGeographic: Korea, Republic of
      PrevalenceQualification: Value and class
      PrevalenceType: Point prevalence
      Source: 32668217[PMID]
      ValMoy: no data
  - Prevalence:
      PrevalenceClass: 1-9 / 1 000 000
      PrevalenceGeographic: Philippines
      PrevalenceQualification: Value and class
      PrevalenceType: Point prevalence
      Source: 32668217[PMID]
      ValMoy: no data
  - Prevalence:
      PrevalenceClass: 1-9 / 100 000
      PrevalenceGeographic: Singapore
      PrevalenceQualification: Value and class
      PrevalenceType: Point prevalence
      Source: 32668217[PMID]
      ValMoy: no data
  - Prevalence:
      PrevalenceClass: 1-9 / 100 000
      PrevalenceGeographic: Taiwan, Province of China
      PrevalenceQualification: Value and class
      PrevalenceType: Point prevalence
      Source: 32668217[PMID]
      ValMoy: no data
  - Prevalence:
      PrevalenceClass: 1-9 / 100 000
      PrevalenceGeographic: Bahrain
      PrevalenceQualification: Value and class
      PrevalenceType: Point prevalence
      Source: 32668217[PMID]
      ValMoy: no data
  - Prevalence:
      PrevalenceClass: 1-5 / 10 000
      PrevalenceGeographic: Iran, Islamic Republic of
      PrevalenceQualification: Value and class
      PrevalenceType: Point prevalence
      Source: 32668217[PMID]
      ValMoy: no data
  - Prevalence:
      PrevalenceClass: 1-9 / 100 000
      PrevalenceGeographic: Iraq
      PrevalenceQualification: Value and class
      PrevalenceType: Point prevalence
      Source: 32668217[PMID]
      ValMoy: no data
  - Prevalence:
      PrevalenceClass: 1-5 / 10 000
      PrevalenceGeographic: Israel
      PrevalenceQualification: Value and class
      PrevalenceType: Point prevalence
      Source: 32668217[PMID]
      ValMoy: no data
  - Prevalence:
      PrevalenceClass: 1-9 / 100 000
      PrevalenceGeographic: Saudi Arabia
      PrevalenceQualification: Value and class
      PrevalenceType: Point prevalence
      Source: 32668217[PMID]
      ValMoy: no data
  - Prevalence:
      PrevalenceClass: 1-5 / 10 000
      PrevalenceGeographic: Egypt
      PrevalenceQualification: Value and class
      PrevalenceType: Point prevalence
      Source: 32668217[PMID]
      ValMoy: no data
  - Prevalence:
      PrevalenceClass: 1-5 / 10 000
      PrevalenceGeographic: Tunisia
      PrevalenceQualification: Value and class
      PrevalenceType: Point prevalence
      Source: 32668217[PMID]
      ValMoy: no data
  - Prevalence:
      PrevalenceClass: 1-5 / 10 000
      PrevalenceGeographic: Austria
      PrevalenceQualification: Value and class
      PrevalenceType: Point prevalence
      Source: 32668217[PMID]
      ValMoy: no data
  - Prevalence:
      PrevalenceClass: 1-5 / 10 000
      PrevalenceGeographic: Belarus
      PrevalenceQualification: Value and class
      PrevalenceType: Point prevalence
      Source: 32668217[PMID]
      ValMoy: no data
  - Prevalence:
      PrevalenceClass: 1-5 / 10 000
      PrevalenceGeographic: Bosnia and Herzegovina
      PrevalenceQualification: Value and class
      PrevalenceType: Point prevalence
      Source: 32668217[PMID]
      ValMoy: no data
  - Prevalence:
      PrevalenceClass: 1-9 / 100 000
      PrevalenceGeographic: Bulgaria
      PrevalenceQualification: Value and class
      PrevalenceType: Point prevalence
      Source: 32668217[PMID]
      ValMoy: no data
  - Prevalence:
      PrevalenceClass: 1-5 / 10 000
      PrevalenceGeographic: Croatia
      PrevalenceQualification: Value and class
      PrevalenceType: Point prevalence
      Source: 32668217[PMID]
      ValMoy: no data
  - Prevalence:
      PrevalenceClass: 1-9 / 100 000
      PrevalenceGeographic: Cyprus
      PrevalenceQualification: Value and class
      PrevalenceType: Point prevalence
      Source: 32668217[PMID]
      ValMoy: no data
  - Prevalence:
      PrevalenceClass: 1-5 / 10 000
      PrevalenceGeographic: Czech Republic
      PrevalenceQualification: Value and class
      PrevalenceType: Point prevalence
      Source: 32668217[PMID]
      ValMoy: no data
  - Prevalence:
      PrevalenceClass: 1-9 / 100 000
      PrevalenceGeographic: Denmark
      PrevalenceQualification: Value and class
      PrevalenceType: Point prevalence
      Source: 32668217[PMID]
      ValMoy: no data
  - Prevalence:
      PrevalenceClass: 1-5 / 10 000
      PrevalenceGeographic: Estonia
      PrevalenceQualification: Value and class
      PrevalenceType: Point prevalence
      Source: 32668217[PMID]
      ValMoy: no data
  - Prevalence:
      PrevalenceClass: 1-5 / 10 000
      PrevalenceGeographic: Germany
      PrevalenceQualification: Value and class
      PrevalenceType: Point prevalence
      Source: 32668217[PMID]
      ValMoy: no data
  - Prevalence:
      PrevalenceClass: 1-9 / 100 000
      PrevalenceGeographic: Greece
      PrevalenceQualification: Value and class
      PrevalenceType: Point prevalence
      Source: 32668217[PMID]
      ValMoy: no data
  - Prevalence:
      PrevalenceClass: 1-5 / 10 000
      PrevalenceGeographic: Hungary
      PrevalenceQualification: Value and class
      PrevalenceType: Point prevalence
      Source: 32668217[PMID]
      ValMoy: no data
  - Prevalence:
      PrevalenceClass: 1-5 / 10 000
      PrevalenceGeographic: Italy
      PrevalenceQualification: Value and class
      PrevalenceType: Point prevalence
      Source: 32668217[PMID]`
      ValMoy: no data
  - Prevalence:
      PrevalenceClass: 1-5 / 10 000
      PrevalenceGeographic: Latvia
      PrevalenceQualification: Value and class
      PrevalenceType: Point prevalence
      Source: 32668217[PMID]
      ValMoy: no data
  - Prevalence:
      PrevalenceClass: 1-5 / 10 000
      PrevalenceGeographic: Lithuania
      PrevalenceQualification: Value and class
      PrevalenceType: Point prevalence
      Source: 32668217[PMID]
      ValMoy: no data
  - Prevalence:
      PrevalenceClass: 1-5 / 10 000
      PrevalenceGeographic: Moldova, Republic of
      PrevalenceQualification: Value and class
      PrevalenceType: Point prevalence
      Source: 32668217[PMID]
      ValMoy: no data
  - Prevalence:
      PrevalenceClass: 1-9 / 100 000
      PrevalenceGeographic: Netherlands
      PrevalenceQualification: Value and class
      PrevalenceType: Point prevalence
      Source: 32668217[PMID]
      ValMoy: no data
  - Prevalence:
      PrevalenceClass: 1-9 / 100 000
      PrevalenceGeographic: Norway
      PrevalenceQualification: Value and class
      PrevalenceType: Point prevalence
      Source: 32668217[PMID]
      ValMoy: no data
  - Prevalence:
      PrevalenceClass: 1-5 / 10 000
      PrevalenceGeographic: Poland
      PrevalenceQualification: Value and class
      PrevalenceType: Point prevalence
      Source: 32668217[PMID]
      ValMoy: no data
  - Prevalence:
      PrevalenceClass: 1-9 / 100 000
      PrevalenceGeographic: Portugal
      PrevalenceQualification: Value and class
      PrevalenceType: Point prevalence
      Source: 32668217[PMID]
      ValMoy: no data
  - Prevalence:
      PrevalenceClass: 1-5 / 10 000
      PrevalenceGeographic: Romania
      PrevalenceQualification: Value and class
      PrevalenceType: Point prevalence
      Source: 32668217[PMID]
      ValMoy: no data
  - Prevalence:
      PrevalenceClass: 1-5 / 10 000
      PrevalenceGeographic: Russian Federation
      PrevalenceQualification: Value and class
      PrevalenceType: Point prevalence
      Source: 32668217[PMID]
      ValMoy: no data
  - Prevalence:
      PrevalenceClass: 1-9 / 100 000
      PrevalenceGeographic: Serbia
      PrevalenceQualification: Value and class
      PrevalenceType: Point prevalence
      Source: 32668217[PMID]
      ValMoy: no data
  - Prevalence:
      PrevalenceClass: 1-5 / 10 000
      PrevalenceGeographic: Slovakia
      PrevalenceQualification: Value and class
      PrevalenceType: Point prevalence
      Source: 32668217[PMID]
      ValMoy: no data
  - Prevalence:
      PrevalenceClass: 1-9 / 100 000
      PrevalenceGeographic: Slovenia
      PrevalenceQualification: Value and class
      PrevalenceType: Point prevalence
      Source: 34082800[PMID]_ORPHANET
      ValMoy: no data
  - Prevalence:
      PrevalenceClass: 1-9 / 100 000
      PrevalenceGeographic: Spain
      PrevalenceQualification: Value and class
      PrevalenceType: Point prevalence
      Source: 32668217[PMID]
      ValMoy: no data
  - Prevalence:
      PrevalenceClass: 1-9 / 100 000
      PrevalenceGeographic: Sweden
      PrevalenceQualification: Value and class
      PrevalenceType: Point prevalence
      Source: 32668217[PMID]
      ValMoy: no data
  - Prevalence:
      PrevalenceClass: 1-5 / 10 000
      PrevalenceGeographic: Switzerland
      PrevalenceQualification: Value and class
      PrevalenceType: Point prevalence
      Source: 32668217[PMID]
      ValMoy: no data
  - Prevalence:
      PrevalenceClass: 1-5 / 10 000
      PrevalenceGeographic: Ukraine
      PrevalenceQualification: Value and class
      PrevalenceType: Point prevalence
      Source: 32668217[PMID]
      ValMoy: no data
  - Prevalence:
      PrevalenceClass: 1-9 / 100 000
      PrevalenceGeographic: Canada
      PrevalenceQualification: Value and class
      PrevalenceType: Point prevalence
      Source: 32668217[PMID]
      ValMoy: no data
  - Prevalence:
      PrevalenceClass: 1-9 / 100 000
      PrevalenceGeographic: New Caledonia
      PrevalenceQualification: Value and class
      PrevalenceType: Point prevalence
      Source: 32668217[PMID]
      ValMoy: no data
  - Prevalence:
      PrevalenceClass: 1-9 / 100 000
      PrevalenceGeographic: New Zealand
      PrevalenceQualification: Value and class
      PrevalenceType: Point prevalence
      Source: 32668217[PMID]
      ValMoy: no data
  - Prevalence:
      PrevalenceClass: 1-9 / 100 000
      PrevalenceGeographic: Argentina
      PrevalenceQualification: Value and class
      PrevalenceType: Point prevalence
      Source: 32668217[PMID]
      ValMoy: no data
  - Prevalence:
      PrevalenceClass: 1-9 / 100 000
      PrevalenceGeographic: Chile
      PrevalenceQualification: Value and class
      PrevalenceType: Point prevalence
      Source: 32668217[PMID]
      ValMoy: no data
  - Prevalence:
      PrevalenceClass: 1-9 / 100 000
      PrevalenceGeographic: Costa rica
      PrevalenceQualification: Value and class
      PrevalenceType: Point prevalence
      Source: 32668217[PMID]
      ValMoy: no data
  - Prevalence:
      PrevalenceClass: 1-9 / 100 000
      PrevalenceGeographic: Mexico
      PrevalenceQualification: Value and class
      PrevalenceType: Point prevalence
      Source: 32668217[PMID]
      ValMoy: no data
  - Prevalence:
      PrevalenceClass: 1-9 / 100 000
      PrevalenceGeographic: Peru
      PrevalenceQualification: Value and class
      PrevalenceType: Point prevalence
      Source: 32668217[PMID]
      ValMoy: no data
  - Prevalence:
      PrevalenceClass: 1-9 / 100 000
      PrevalenceGeographic: Cuba
      PrevalenceQualification: Value and class
      PrevalenceType: Point prevalence
      Source: 32668217[PMID]
      ValMoy: no data
  - Prevalence:
      PrevalenceClass: 1-9 / 100 000
      PrevalenceGeographic: Worldwide
      PrevalenceQualification: Value and class
      PrevalenceType: Point prevalence
      Source: 32668217[PMID]
      ValMoy: no data
  - Prevalence:
      PrevalenceClass: 1-5 / 10 000
      PrevalenceGeographic: India
      PrevalenceQualification: Value and class
      PrevalenceType: Prevalence at birth
      Source: 32668217[PMID]_ORPHANET
      ValMoy: no data
  - Prevalence:
      PrevalenceClass: 1-5 / 10 000
      PrevalenceGeographic: Pakistan
      PrevalenceQualification: Value and class
      PrevalenceType: Prevalence at birth
      Source: 32668217[PMID]
      ValMoy: no data
  - Prevalence:
      PrevalenceClass: 1-9 / 100 000
      PrevalenceGeographic: Saudi Arabia
      PrevalenceQualification: Value and class
      PrevalenceType: Prevalence at birth
      Source: 34082800[PMID]
      ValMoy: no data
  - Prevalence:
      PrevalenceClass: 1-9 / 100 000
      PrevalenceGeographic: Austria
      PrevalenceQualification: Value and class
      PrevalenceType: Prevalence at birth
      Source: 34082800[PMID]_ORPHANET
      ValMoy: no data
  - Prevalence:
      PrevalenceClass: 1-5 / 10 000
      PrevalenceGeographic: Estonia
      PrevalenceQualification: Value and class
      PrevalenceType: Prevalence at birth
      Source: 34082800[PMID]
      ValMoy: no data
  - Prevalence:
      PrevalenceClass: 1-9 / 100 000
      PrevalenceGeographic: Germany
      PrevalenceQualification: Value and class
      PrevalenceType: Prevalence at birth
      Source: 34082800[PMID]_ORPHANET
      ValMoy: no data
  - Prevalence:
      PrevalenceClass: 1-9 / 100 000
      PrevalenceGeographic: Greece
      PrevalenceQualification: Value and class
      PrevalenceType: Prevalence at birth
      Source: 34082800[PMID]_ORPHANET
      ValMoy: no data
  - Prevalence:
      PrevalenceClass: 1-9 / 100 000
      PrevalenceGeographic: Hungary
      PrevalenceQualification: Value and class
      PrevalenceType: Prevalence at birth
      Source: 34082800[PMID]
      ValMoy: no data
  - Prevalence:
      PrevalenceClass: 1-9 / 100 000
      PrevalenceGeographic: Italy
      PrevalenceQualification: Value and class
      PrevalenceType: Prevalence at birth
      Source: 34082800[PMID]_ORPHANET
      ValMoy: no data
  - Prevalence:
      PrevalenceClass: 1-5 / 10 000
      PrevalenceGeographic: North Macedonia
      PrevalenceQualification: Value and class
      PrevalenceType: Prevalence at birth
      Source: 34082800[PMID]_ORPHANET
      ValMoy: no data
  - Prevalence:
      PrevalenceClass: 1-9 / 100 000
      PrevalenceGeographic: Poland
      PrevalenceQualification: Value and class
      PrevalenceType: Prevalence at birth
      Source: 34082800[PMID]_ORPHANET
      ValMoy: no data
  - Prevalence:
      PrevalenceClass: 1-9 / 100 000
      PrevalenceGeographic: Portugal
      PrevalenceQualification: Value and class
      PrevalenceType: Prevalence at birth
      Source: 34082800[PMID]_ORPHANET
      ValMoy: no data
  - Prevalence:
      PrevalenceClass: 1-5 / 10 000
      PrevalenceGeographic: Slovakia
      PrevalenceQualification: Value and class
      PrevalenceType: Prevalence at birth
      Source: 34082800[PMID]
      ValMoy: no data
  - Prevalence:
      PrevalenceClass: 1-9 / 100 000
      PrevalenceGeographic: Spain
      PrevalenceQualification: Value and class
      PrevalenceType: Prevalence at birth
      Source: 34082800[PMID]
      ValMoy: no data
  - Prevalence:
      PrevalenceClass: 1-9 / 100 000
      PrevalenceGeographic: Chile
      PrevalenceQualification: Value and class
      PrevalenceType: Prevalence at birth
      Source: 34082800[PMID]_ORPHANET
      ValMoy: no data
  - Prevalence:
      PrevalenceClass: 1-9 / 100 000
      PrevalenceGeographic: Iran, Islamic Republic of
      PrevalenceQualification: Value and class
      PrevalenceType: Prevalence at birth
      Source: 34082800[PMID]_ORPHANET
      ValMoy: no data
  - Prevalence:
      PrevalenceClass: 1-9 / 100 000
      PrevalenceGeographic: Canada
      PrevalenceQualification: Value and class
      PrevalenceType: Prevalence at birth
      Source: 34082800[PMID]_ORPHANET
      ValMoy: no data
  - Prevalence:
      PrevalenceClass: 1-9 / 100 000
      PrevalenceGeographic: Korea, Republic of
      PrevalenceQualification: Value and class
      PrevalenceType: Prevalence at birth
      Source: 34082800[PMID]
      ValMoy: no data
  - Prevalence:
      PrevalenceClass: 1-9 / 100 000
      PrevalenceGeographic: Taiwan, Province of China
      PrevalenceQualification: Value and class
      PrevalenceType: Prevalence at birth
      Source: 34082800[PMID]_ORPHANET
      ValMoy: no data
  - Prevalence:
      PrevalenceClass: 1-9 / 100 000
      PrevalenceGeographic: Worldwide
      PrevalenceQualification: Value and class
      PrevalenceType: Prevalence at birth
      Source: 34082800[PMID]
      ValMoy: no data
  Synonyms:
  - Synonym: PAH deficiency
  - Synonym: PKU
  - Synonym: Phenylalanine hydroxylase deficiency
  TextSection:
    Contents: A rare inborn error of amino acid metabolism characterized by elevated
      blood phenylalanine and low levels or absence of phenylalanine hydroxylase enzyme.
      If not detected early or left untreated the disorder manifests with mild to
      severe mental disability.
    TextSectionType: Definition
  TypeOfInheritances:
    TypeOfInheritance:
    - value: Autosomal recessive
  copyright: Orphanet (c) 2023
  creationDate: '2023-06-22 11:33:23'
  version: 1.3.25 / 4.1.7 [2023-04-17] (orientdb version)
